Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
<h4>Background</h4>Patients who have had an unprovoked deep venous thrombosis (DVT) or pulmonary embolus (PE) are at a high risk for recurrent venous thromboembolism (VTE). Extended "life-long" anticoagulation has been recommended in these patients. However, the risk benefit ra...
Saved in:
| Main Authors: | Paul E Marik, Rodrigo Cavallazzi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0143252 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aspirin for the extended prevention of venous thromboembolism: a meta-analysis and trial sequential analysis
by: Michele Carron, et al.
Published: (2025-05-01) -
Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants
by: Zohreh Gholizadeh Ghozloujeh, et al.
Published: (2025-05-01) -
Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01) -
Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
by: A T Cohen, et al.
Published: (2016-01-01) -
Aspirin for thromboembolic complication prevention in cardiovascular disease: dose optimization and adverse effect minimization
by: A. N. Britov
Published: (2006-12-01)